Eli Lilly and Company reports a significant shift in Ulcerative Colitis (UC) treatment, with Omvoh sustaining disease clearance in patients for more than four years, setting a new standard in UC care.
Ajanta Pharma reported strong growth in its Ajanta Pharma Q4 results, with both domestic and global businesses driving performance for the quarter ended March 31, 2026. Revenue from operations rose 21 percent year-on-year to Rs 1,422 crore...
Nutrition aid for TB patients, TB patients in India, and efforts to reduce tuberculosis deaths could save nearly 1.2 lakh lives every year, according to a new study that highlights the critical link between food support and tuberculosis treatme...
India’s pharma exports crossed the $31 billion mark in FY26 despite a challenging global business environment and slower demand in some international markets. The strong growth highlights the resilience of the Indian pharmaceutical indust...
Emcure Pharmaceuticals reported a strong finish to the fiscal year, with Q4 profit showing a 24 percent year-on-year rise in net profit to Rs 243.74 crore. The company’s latest earnings highlight steady business momentum driven by solid demand...
India’s Pharma Industry exports surpassed USD 31 billion in FY26, as per official data, even as shipments witnessed a steep decline in March due to global tensions.
Diabetes treatment access is set to improve in Canada after Orbicular Pharmaceutical Technologies announced it has received a Notice of Compliance (NOC) from Health Canada for its semaglutide injection, developed in partnership with Apotex Inc....
Union Minister Jitendra Singh stressed that government academia industry collaboration is key to driving scientific progress in India, urging stakeholders to work together in a more connected and practical way to strengthen the country’s innovati...
In a significant development, an advisory panel of the U.S. Food and Drug Administration (FDA) has backed AstraZeneca’s prostate cancer combination therapy in a key vote, strengthening its chances of regulatory approval and offering new hop...
OneSource partners have secured Canada approval, generic semaglutide injection, a major step that could make diabetes treatment more affordable while boosting competition in the rapidly growing GLP-1 drug market.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")